About
AboutNovo GroupLeadershipResponsibilityNovo Nordisk Foundation
Investments
InvestmentsAreas
Life Science
Seed InvestmentsVenture InvestmentsGrowth InvestmentsPrincipal InvestmentsBioindustrial Investments
Capital Investments
StrategyRegions
North AmericaEuropeAsia
Portfolio
People & Careers
PeopleCareers
Open positions
News & Reports
News & ReportsFacts & figuresPress FAQMedia library
Carol Wang

Department

Novo Holdings Equity Asia

Position

Senior Associate

Carol joined Novo Holdings Asia in 2021 as Senior Associate. She participates in deal sourcing and execution as well as in managing and developing the growing portfolio of investments, focusing primarily on the markets in China, India, and Southeast Asia.

Prior to joining Novo Holdings Asia, Carol was Senior Investment Manager at Fosun International in Shanghai for more than 4 years. During this time, she worked on both private and public healthcare investment opportunities across the Asia-Pacific region. Before this, Carol worked as  Equity Research Associate at UBS covering Greater China healthcare sector listed in HK and US, and Portfolio Manager Assistant at Raymond James in Toronto.

Carol holds an MBA with major in Finance from McMaster University in Canada.

Investing to benefit people and the planet

Novo Holdings A/S

Tuborg Havnevej 19

2900 Hellerup Denmark

+45 3527 6500 CVR# 24257630

Media Relations

Christian Mostrup Scheel

Head of Public Relations

cims@novo.dk +45 3067 4805

Novo Holdings Equity US Inc.*

One Market Plaza, Floor 17 of the Steuart Tower

San Francisco, CA 94105 USA

+1 (415) 363-0858

Novo Holdings Equity Asia Pte. Ltd.*

#40-01, 6 Battery Road

Singapore 049909

Novo Holdings Equity US Inc.*

200 Clarendon Street, Floor 45

Boston, MA 02116 USA

Novo Holdings (UK office)

16 Berkeley Street

London W1J 8DZ

Novo Ventures (US) Inc.*

200 Clarendon Street, Floor 45

Boston, MA 02116 USA

Privacy noticeWhistleblowerArticles of association Policy on data ethicsElectronic invoicingDiversity policy

*Novo Ventures (US) Inc., Novo Holdings Equity US Inc., comprising Novo Growth and Principal Investments, and Novo Holdings Equity Asia Pte. Ltd. are separate legal entities that provide certain consultancy services to Novo Holdings A/S, mainly within the areas of identifying, analysing and negotiating various investment opportunities among life science and biotech companies in the US as well as certain follow-up activities related thereto, such as board memberships, financial control and reporting efforts.

Follow us